Results 271 to 280 of about 239,349 (307)
Some of the next articles are maybe not open access.
Hyperuricemia and Bone Marrow Transplantation
2004Blood uric acid levels and purine metabolism are affected in many ways after bone marrow transplantation (BMT). Although BMT is usually performed when patients have a low residual disease burden, a proportion of them are still at risk of tumor lysis syndrome, even with limited disease or after nonmyeloablative conditioning regimens; moreover, an ...
Giorgio Lambertenghi, Deliliers +1 more
openaire +2 more sources
Allogeneic bone marrow transplantation
Seminars in Oncology Nursing, 1994From highly investigational to standardized therapy, allogeneic BMT has established its role in the treatment of selected diseases. Continued refinements in bone marrow transplantation will increase the number of potential candidates, reduce associated risks, and improve disease-free survival rates.
T, Franco, D A, Gould
openaire +2 more sources
Sinusitis in Bone Marrow Transplantation
Southern Medical Journal, 1994Bone marrow transplantation has become a beneficial and curative technique used in treatment of patients with different hematologic conditions. It has become widely used at our institution for hematologic malignancies and certain resistant solid tumors. However, this treatment can result in immunosuppression, with an increased chance of infection.
S, Yee +3 more
openaire +2 more sources
The pathology of bone marrow transplantation
Histopathology, 1993The pathological complications of bone marrow transplantation are complex and may affect any organ in the body. The causes are often multifactorial and include the effects of chemotherapy, the conditioning regimen, drugs used in the post‐transplant period such as immunosuppressants and antibiotics, graft‐versus‐host disease (GvHD) and the effects of ...
J P, Sloane, J, Norton
openaire +2 more sources
Transfusion and Bone Marrow Transplantation
Transfusion Medicine Reviews, 1988Bone marrow transplantation has prolonged the lives of a significant percentage of patients with a variety of both malignant and nonmalignant disorders. However, the impact of this treatment on a transfusion service is substantial. Large numbers of often specialized blood products are required to support these patients, and the logistics of ...
openaire +2 more sources
Mesna and Bone-Marrow Transplantation
New England Journal of Medicine, 1982R, Becher, S, Kakati, A A, Sandberg
openaire +2 more sources